Furthermore, plasma levels of markers considered specific, such as MPO-DNA appear to be less sensitive in discriminating severity than other NETs measurement methods, such as NETosis induction in plasma samples, as has been recently reported in patients with COVID-19 [32]. The gene discussed is MPO; the disease is COVID-19.